Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum NetraMark Holdings Inc AINMF


Primary Symbol: C.AIAI

NetraMark Holdings Inc. is a Canada-based company, which is focused on the development of Generative Artificial Intelligence (Gen AI)/Machine Learning (ML) solutions targeted at the pharmaceutical industry. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several... see more

CSE:AIAI - Post Discussion

View:
Post by yopmemama021 on Apr 13, 2022 5:14pm

MEND

$MEND.c up 6.4% today following some big news for the company 

 

$MEND is entering the oncology healthcare sphere in partnering  with the Ontario Insititue for Cancer Research (OICR) 

 

 

 $MNNDF ’s AI will be used to leverage genome sequencing data surrounding pancreatic cancer, in hopes of identifying genetic biomarkers for the disease.Pancreatic cancer has a 5-year survival rate of just 10%

 

Very excited to see $MEND progressing healthcare in hopes of saving lives while and entering this domain( whose therapeutics market is worth USD $2.59 Billion)

 

https://www.newswire.ca/news-releases/nurosene-announces-research-partnership-in-oncology-with-the-ontario-institute-for-cancer-research-850422136.html

 

mc $20.14M

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities